The 5-HT2A (serotonin2A) receptor gene in the aetiology,pathophysiology and pharmacotherapy of schizophrenia

Arranz M.J. , Lin M-W. , Powell J. , Kerwin R. , Collier D. (1996) 5-HT2A receptor T102C polymorphism and schizophrenia. Lancet 347: 1831

Burnet P W J , Harrison P.J. (1995) Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet 346: 909

Burnet P W J , Eastwood S.L. , Lacey K.L. , Harrison P.J. (1995) The distribution of 5-HT1A and 5-HT 2A receptor mRNAs in human brain. Brain Res 676: 157-168

Burnet P W J , Chen C P L-H , McGowan S. , Franklin M. , Harrison P.J. (1996a) The effects of clozapine and haloperidol on serotonin-1A, -2A, and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience 73: 531-540

Burnet P W J , Eastwood S.L. , Harrison P.J. (1996b) 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially affected in schizophrenia . Neuropsychopharmacology 15: 422-435

Clifford C.P. , Nunez D J R (1996) 5-HT2A receptor T102C polymorphism and schizophrenia. Lancet 347: 1830

Crow T.J. (1996) 5-HT2A receptor T102C polymorphism and schizophrenia. Lancet 347:1832

Crowe R.R. (1993) Candidate genes in psychiatry: an epidemiological perspective. Am J Med Genet (Neuropsychiat Genet) 48: 74-77

Harrison P.J. , Geddes J.R. (1996) Schizophrenia and the 5-HT2A receptor gene [Commentary]. Lancet 347: 1274

Inayama Y. , Yoneda H. , Sakai T. , Ishida T. , Nonomura Y. , Kono Y. , Takahata R. , Koh J. , Sakai J. , Takai A. , Inada Y. , Asaba H. (1996) Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet 67: 103-105

Ishigaki T. , Xie D-W. , Liu J-C. , Nakamura Y. , Zhang H-Y. , Tani K. , Shimazu Y. , Chen K. , Shih J.C. , Miyatso K. , Ohara K. , Ohara K. (1996) Intact 5-HT2A receptor exons and adjoining intron regions in schizophrenia. Neuropsychopharmacology 14: 339-347 Jonsson E. , Nothen M.M. , Bunzel R. , Propping P. , Sedvall G. (1996) 5-HT2a receptor T102C polymorphism and schizophrenia. Lancet 347: 1831

Kerwin R.W. , Dumon V. (1994) Dopamine receptor genes and schizophrenia: the tail wags the dog? Lancet 343: 686

Kidd K.K. (1993) Associations of disease with genetic markers: déjà vu all over again. Am J Med Genet (Neuropsychiat Genet) 48: 71-73

Kuoppamäki M. , Palvimäki E-P. , Hietala J. , Syvalähti E. (1995) Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology 13:139-150

Malhotra A.K. , Goldman D. , Buchanan R. , Breier A. , Pickar D. (1996) 5-HT2a receptor T102C polymorphism and schizophrenia. Lancet 347:1830-1831

Masellis M. , Paterson A.D. , Badri F. , Lieberman J.A. , Meltzer H.Y. , Cavazzoni P. , Kennedy J.L. (1996) Genetic variation of 5-HT2A receptor and response to clozapine. Lancet 346: 908-909

Mui S. , Briggs M. , Chung H. , Wallace R.B. , Gomez-IslaT. , Rebeck G.W. , Hyman B.T. (1996) A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the ε4 allele. Neurology 47: 196-201

Nöthen M.M. , Rietschel M. , Erdmann J. , Oberlander H. , Moller H.J. , Naber D. , Propping P. (1996) Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet 346: 1108

Owen M.J. , McGuflin P. (1993) Association and linkage: complementary strategies for complex disorders. J Med Genet 30: 638-639

Sasaki T. , Hattori M. , Fukuda R. , Kunugi H. , Nanko S. (1996) 5-HT2A receptor T102C polymorphism and schizophrenia. Lancet 347: 1832

Strittmatter W.J. , Roses A.D. (1996) Apolipoprotein E and Alzheimer's disease. Ann Rev Neurosci 19: 53-77

Williams J. , Spurlock G. , McGuffin P. , Mallet J. , Nothen M.M. , Gill M. , Aschauer H. , Nylander P.O. , Macciarfi F. , Owen M.J. (1996) Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. Lancet 347: 1294-1296